Our group has firstly reported the achievement of successful demethylation of EBV viral antigen promoters including Cp, Wp, LMP1p, Zp and Rp, in NPC patients with azacitidine treatment [1,10-12]. This evidence concerns the gene CP and nasopharyngeal carcinoma.